APO Research
Talk to an analyst

APO RESEARCH · REPORT

Equine Pharmaceuticals and Supplements

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Selected research

Industry Research

Equine Pharmaceuticals and Supplements Industry Research Report 2026

21 December 2025129 pages

Choose your research edition.

Industry ResearchEquine Pharmaceuticals and Supplements Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Pharmaceuticals and Supplements Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Equine Pharmaceuticals and Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Pharmaceuticals and Supplements Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Pharmaceuticals and Supplements Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%.

North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent.

Read the full market overview

In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.

Report Scope

This report quantifies the global Equine Pharmaceuticals and Supplements market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Equine Pharmaceuticals and Supplements Market by Company

Boehringer Ingelheim

Merck Animal Health

Zoetis

Bayer Animal Health

Elanco Animal Health

Dechra Veterinary Products

CEVA

Virbac

Norbrook Equine

Kyoritsu Seiyaku

Vetoquinol

Protexin Healthcare

Audevard

Ouro Fino Saude

Equine Pharmaceuticals and Supplements Segment by Type

Pharmaceuticals

Supplements

Equine Pharmaceuticals and Supplements Segment by Application

Thoroughbred Horse

Other Types of Horses

Equine Pharmaceuticals and Supplements Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Pharmaceuticals and Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Pharmaceuticals and Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Pharmaceuticals and Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Equine Pharmaceuticals and Supplements manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Equine Pharmaceuticals and Supplements by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Equine Pharmaceuticals and Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Equine Pharmaceuticals and Supplements Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Equine Pharmaceuticals and Supplements Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturers (2021-2026) Table 8. Global Equine Pharmaceuticals and Supplements Revenue of Manufacturers (2021-2026) Table 9. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/Unit) of Manufacturers (2021-2026) Table 11. Global Equine Pharmaceuticals and Supplements Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Equine Pharmaceuticals and Supplements, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Equine Pharmaceuticals and Supplements, Product Type & Application Table 14. Global Equine Pharmaceuticals and Supplements Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Equine Pharmaceuticals and Supplements by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Boehringer Ingelheim Company Information Table 19. Boehringer Ingelheim Business Overview Table 20. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 21. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio Table 22. Boehringer Ingelheim Recent Developments Table 23. Merck Animal Health Company Information Table 24. Merck Animal Health Business Overview Table 25. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 26. Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 27. Merck Animal Health Recent Developments Table 28. Zoetis Company Information Table 29. Zoetis Business Overview Table 30. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 31. Zoetis Equine Pharmaceuticals and Supplements Product Portfolio Table 32. Zoetis Recent Developments Table 33. Bayer Animal Health Company Information Table 34. Bayer Animal Health Business Overview Table 35. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 36. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 37. Bayer Animal Health Recent Developments Table 38. Elanco Animal Health Company Information Table 39. Elanco Animal Health Business Overview Table 40. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 41. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 42. Elanco Animal Health Recent Developments Table 43. Dechra Veterinary Products Company Information Table 44. Dechra Veterinary Products Business Overview Table 45. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 46. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio Table 47. Dechra Veterinary Products Recent Developments Table 48. CEVA Company Information Table 49. CEVA Business Overview Table 50. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 51. CEVA Equine Pharmaceuticals and Supplements Product Portfolio Table 52. CEVA Recent Developments Table 53. Virbac Company Information Table 54. Virbac Business Overview Table 55. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 56. Virbac Equine Pharmaceuticals and Supplements Product Portfolio Table 57. Virbac Recent Developments Table 58. Norbrook Equine Company Information Table 59. Norbrook Equine Business Overview Table 60. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio Table 62. Norbrook Equine Recent Developments Table 63. Kyoritsu Seiyaku Company Information Table 64. Kyoritsu Seiyaku Business Overview Table 65. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio Table 67. Kyoritsu Seiyaku Recent Developments Table 68. Vetoquinol Company Information Table 69. Vetoquinol Business Overview Table 70. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio Table 72. Vetoquinol Recent Developments Table 73. Protexin Healthcare Company Information Table 74. Protexin Healthcare Business Overview Table 75. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio Table 77. Protexin Healthcare Recent Developments Table 78. Audevard Company Information Table 79. Audevard Business Overview Table 80. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Audevard Equine Pharmaceuticals and Supplements Product Portfolio Table 82. Audevard Recent Developments Table 83. Ouro Fino Saude Company Information Table 84. Ouro Fino Saude Business Overview Table 85. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio Table 87. Ouro Fino Saude Recent Developments Table 88. Global Equine Pharmaceuticals and Supplements Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Equine Pharmaceuticals and Supplements Sales by Region (2021-2026) & (K Units) Table 90. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2021-2026) Table 91. Global Equine Pharmaceuticals and Supplements Sales by Region (2027-2032) & (K Units) Table 92. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2027-2032) Table 93. Global Equine Pharmaceuticals and Supplements Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2021-2026) Table 95. Global Equine Pharmaceuticals and Supplements Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2027-2032) Table 97. North America Equine Pharmaceuticals and Supplements Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 99. North America Equine Pharmaceuticals and Supplements Sales by Country (2027-2032) & (K Units) Table 100. North America Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Equine Pharmaceuticals and Supplements Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Equine Pharmaceuticals and Supplements Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 104. Europe Equine Pharmaceuticals and Supplements Sales by Country (2027-2032) & (K Units) Table 105. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 109. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Country (2027-2032) & (K Units) Table 110. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Equine Pharmaceuticals and Supplements Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 114. South America Equine Pharmaceuticals and Supplements Sales by Country (2027-2032) & (K Units) Table 115. South America Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Equine Pharmaceuticals and Supplements Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 119. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2027-2032) & (K Units) Table 120. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units) Table 123. Global Equine Pharmaceuticals and Supplements Sales by Type (2027-2032) & (K Units) Table 124. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2021-2026) Table 125. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2027-2032) Table 126. Global Equine Pharmaceuticals and Supplements Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Equine Pharmaceuticals and Supplements Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2026) Table 129. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2027-2032) Table 130. Global Equine Pharmaceuticals and Supplements Price by Type (2021-2026) & (USD/Unit) Table 131. Global Equine Pharmaceuticals and Supplements Price by Type (2027-2032) & (USD/Unit) Table 132. Global Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units) Table 133. Global Equine Pharmaceuticals and Supplements Sales by Application (2027-2032) & (K Units) Table 134. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2021-2026) Table 135. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2027-2032) Table 136. Global Equine Pharmaceuticals and Supplements Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Equine Pharmaceuticals and Supplements Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2026) Table 139. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2027-2032) Table 140. Global Equine Pharmaceuticals and Supplements Price by Application (2021-2026) & (USD/Unit) Table 141. Global Equine Pharmaceuticals and Supplements Price by Application (2027-2032) & (USD/Unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Equine Pharmaceuticals and Supplements Distributors List Table 145. Equine Pharmaceuticals and Supplements Customers List Table 146. Equine Pharmaceuticals and Supplements Industry Trends Table 147. Equine Pharmaceuticals and Supplements Industry Drivers Table 148. Equine Pharmaceuticals and Supplements Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Equine Pharmaceuticals and Supplements Product Image Figure 5. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Equine Pharmaceuticals and Supplements Market Size (2021-2032) & (US$ Million) Figure 7. Global Equine Pharmaceuticals and Supplements Sales (2021-2032) & (K Units) Figure 8. Global Equine Pharmaceuticals and Supplements Average Price (USD/Unit) & (2021-2032) Figure 9. Pharmaceuticals Product Image Figure 10. Supplements Product Image Figure 11. Thoroughbred Horse Product Image Figure 12. Other Types of Horses Product Image Figure 13. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Equine Pharmaceuticals and Supplements, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Equine Pharmaceuticals and Supplements Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Equine Pharmaceuticals and Supplements Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Equine Pharmaceuticals and Supplements Sales by Region in 2025 Figure 19. Global Equine Pharmaceuticals and Supplements Revenue by Region in 2025 Figure 20. North America Equine Pharmaceuticals and Supplements Market Size by Country in 2025 Figure 21. North America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032) Figure 22. North America Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2021-2032) Figure 23. United States Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Equine Pharmaceuticals and Supplements Market Size by Country in 2025 Figure 27. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032) Figure 28. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2021-2032) Figure 29. Germany Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Country in 2025 Figure 40. Asia Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2021-2032) Figure 42. China Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Equine Pharmaceuticals and Supplements Market Size by Country in 2025 Figure 51. South America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032) Figure 52. South America Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2021-2032) Figure 53. Brazil Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Country in 2025 Figure 57. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2021-2032) Figure 59. Egypt Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Equine Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2021-2032) Figure 65. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2032) Figure 66. Global Equine Pharmaceuticals and Supplements Price (USD/Unit) by Type (2021-2032) Figure 67. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2021-2032) Figure 68. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2032) Figure 69. Global Equine Pharmaceuticals and Supplements Price (USD/Unit) by Application (2021-2032) Figure 70. Equine Pharmaceuticals and Supplements Value Chain Figure 71. Equine Pharmaceuticals and Supplements Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Equine Pharmaceuticals and Supplements Industry Opportunities and Challenges

Scope & coverage.

Types
  • Pharmaceuticals
  • Supplements
Applications
  • Thoroughbred Horse
  • Other Types of Horses
Companies covered
  • Boehringer Ingelheim
  • Merck Animal Health
  • Zoetis
  • Bayer Animal Health
  • Elanco Animal Health
  • Dechra Veterinary Products
  • CEVA
  • Virbac
  • Norbrook Equine
  • Kyoritsu Seiyaku
  • Vetoquinol
  • Protexin Healthcare
  • Audevard
  • Ouro Fino Saude

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Equine Pharmaceuticals and Supplements Market Size (2021-2032)
  4. 2.2.2 Global Equine Pharmaceuticals and Supplements Sales (2021-2032)
  5. 2.2.3 Global Equine Pharmaceuticals and Supplements Market Average Price (2021-2032)
  6. 2.3 Equine Pharmaceuticals and Supplements by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Pharmaceuticals
  9. 2.3.3 Supplements
  10. 2.4 Equine Pharmaceuticals and Supplements by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Thoroughbred Horse
  13. 2.4.3 Other Types of Horses
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Equine Pharmaceuticals and Supplements Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Equine Pharmaceuticals and Supplements Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Equine Pharmaceuticals and Supplements Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Equine Pharmaceuticals and Supplements Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Equine Pharmaceuticals and Supplements, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Equine Pharmaceuticals and Supplements, Product Type & Application
  8. 3.8 Global Manufacturers of Equine Pharmaceuticals and Supplements, Established Date
  9. 3.9 Global Equine Pharmaceuticals and Supplements Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Boehringer Ingelheim
  2. 4.1.1 Boehringer Ingelheim Company Information
  3. 4.1.2 Boehringer Ingelheim Business Overview
  4. 4.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio
  6. 4.1.5 Boehringer Ingelheim Recent Developments
  7. 4.2 Merck Animal Health
  8. 4.2.1 Merck Animal Health Company Information
  9. 4.2.2 Merck Animal Health Business Overview
  10. 4.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  12. 4.2.5 Merck Animal Health Recent Developments
  13. 4.3 Zoetis
  14. 4.3.1 Zoetis Company Information
  15. 4.3.2 Zoetis Business Overview
  16. 4.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Zoetis Equine Pharmaceuticals and Supplements Product Portfolio
  18. 4.3.5 Zoetis Recent Developments
  19. 4.4 Bayer Animal Health
  20. 4.4.1 Bayer Animal Health Company Information
  21. 4.4.2 Bayer Animal Health Business Overview
  22. 4.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  24. 4.4.5 Bayer Animal Health Recent Developments
  25. 4.5 Elanco Animal Health
  26. 4.5.1 Elanco Animal Health Company Information
  27. 4.5.2 Elanco Animal Health Business Overview
  28. 4.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  30. 4.5.5 Elanco Animal Health Recent Developments
  31. 4.6 Dechra Veterinary Products
  32. 4.6.1 Dechra Veterinary Products Company Information
  33. 4.6.2 Dechra Veterinary Products Business Overview
  34. 4.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio
  36. 4.6.5 Dechra Veterinary Products Recent Developments
  37. 4.7 CEVA
  38. 4.7.1 CEVA Company Information
  39. 4.7.2 CEVA Business Overview
  40. 4.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 CEVA Equine Pharmaceuticals and Supplements Product Portfolio
  42. 4.7.5 CEVA Recent Developments
  43. 4.8 Virbac
  44. 4.8.1 Virbac Company Information
  45. 4.8.2 Virbac Business Overview
  46. 4.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Virbac Equine Pharmaceuticals and Supplements Product Portfolio
  48. 4.8.5 Virbac Recent Developments
  49. 4.9 Norbrook Equine
  50. 4.9.1 Norbrook Equine Company Information
  51. 4.9.2 Norbrook Equine Business Overview
  52. 4.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio
  54. 4.9.5 Norbrook Equine Recent Developments
  55. 4.10 Kyoritsu Seiyaku
  56. 4.10.1 Kyoritsu Seiyaku Company Information
  57. 4.10.2 Kyoritsu Seiyaku Business Overview
  58. 4.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio
  60. 4.10.5 Kyoritsu Seiyaku Recent Developments
  61. 4.11 Vetoquinol
  62. 4.11.1 Vetoquinol Company Information
  63. 4.11.2 Vetoquinol Business Overview
  64. 4.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio
  66. 4.11.5 Vetoquinol Recent Developments
  67. 4.12 Protexin Healthcare
  68. 4.12.1 Protexin Healthcare Company Information
  69. 4.12.2 Protexin Healthcare Business Overview
  70. 4.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio
  72. 4.12.5 Protexin Healthcare Recent Developments
  73. 4.13 Audevard
  74. 4.13.1 Audevard Company Information
  75. 4.13.2 Audevard Business Overview
  76. 4.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Audevard Equine Pharmaceuticals and Supplements Product Portfolio
  78. 4.13.5 Audevard Recent Developments
  79. 4.14 Ouro Fino Saude
  80. 4.14.1 Ouro Fino Saude Company Information
  81. 4.14.2 Ouro Fino Saude Business Overview
  82. 4.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio
  84. 4.14.5 Ouro Fino Saude Recent Developments
5 Global Equine Pharmaceuticals and Supplements Market Scenario by Region
  1. 5.1 Global Equine Pharmaceuticals and Supplements Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Equine Pharmaceuticals and Supplements Sales by Region: 2021-2032
  3. 5.2.1 Global Equine Pharmaceuticals and Supplements Sales by Region: 2021-2026
  4. 5.2.2 Global Equine Pharmaceuticals and Supplements Sales by Region: 2027-2032
  5. 5.3 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2021-2032
  6. 5.3.1 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2021-2026
  7. 5.3.2 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2027-2032
  8. 5.4 North America Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
  9. 5.4.1 North America Equine Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Equine Pharmaceuticals and Supplements Sales by Country (2021-2032)
  11. 5.4.3 North America Equine Pharmaceuticals and Supplements Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
  16. 5.5.1 Europe Equine Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Equine Pharmaceuticals and Supplements Sales by Country (2021-2032)
  18. 5.5.3 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
  41. 5.7.1 South America Equine Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Equine Pharmaceuticals and Supplements Sales by Country (2021-2032)
  43. 5.7.3 South America Equine Pharmaceuticals and Supplements Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2021-2032)
  2. 6.1.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2021-2032)
  4. 6.2 Global Equine Pharmaceuticals and Supplements Revenue by Type (2021-2032)
  5. 6.2.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Equine Pharmaceuticals and Supplements Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2021-2032)
  2. 7.1.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2021-2032)
  4. 7.2 Global Equine Pharmaceuticals and Supplements Revenue by Application (2021-2032)
  5. 7.2.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Equine Pharmaceuticals and Supplements Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Equine Pharmaceuticals and Supplements Value Chain Analysis
  2. 8.1.1 Equine Pharmaceuticals and Supplements Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Equine Pharmaceuticals and Supplements Production Mode & Process
  5. 8.2 Equine Pharmaceuticals and Supplements Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Equine Pharmaceuticals and Supplements Distributors
  8. 8.2.3 Equine Pharmaceuticals and Supplements Customers
9 Global Equine Pharmaceuticals and Supplements Analyzing Market Dynamics
  1. 9.1 Equine Pharmaceuticals and Supplements Industry Trends
  2. 9.2 Equine Pharmaceuticals and Supplements Industry Drivers
  3. 9.3 Equine Pharmaceuticals and Supplements Industry Opportunities and Challenges
  4. 9.4 Equine Pharmaceuticals and Supplements Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst